Meds Apotek AB (STO:MEDS)

Meds Apotek AB Statistics

Total Valuation

Meds Apotek AB has a market cap or net worth of SEK 484.73 million. The enterprise value is 446.61 million.

Market Cap	484.73M
Enterprise Value	446.61M

Important Dates

The next confirmed earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Meds Apotek AB has 18.57 million shares outstanding. The number of shares has increased by 3.40% in one year.

Current Share Class	18.57M
Shares Outstanding	18.57M
Shares Change (YoY)	+3.40%
Shares Change (QoQ)	+10.51%
Owned by Insiders (%)	13.05%
Owned by Institutions (%)	19.97%
Float	15.01M

Valuation Ratios

The trailing PE ratio is 60.70 and the forward PE ratio is 17.88.

PE Ratio	60.70
Forward PE	17.88
PS Ratio	0.48
PB Ratio	3.78
P/TBV Ratio	4.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.65, with an EV/FCF ratio of -20.46.

EV / Earnings	57.80
EV / Sales	0.44
EV / EBITDA	52.65
EV / EBIT	n/a
EV / FCF	-20.46

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.05.

Current Ratio	1.63
Quick Ratio	0.58
Debt / Equity	0.05
Debt / EBITDA	0.83
Debt / FCF	-0.32
Interest Coverage	-2.35

Financial Efficiency

Return on equity (ROE) is 8.26% and return on invested capital (ROIC) is -1.38%.

Return on Equity (ROE)	8.26%
Return on Assets (ROA)	-0.63%
Return on Invested Capital (ROIC)	-1.38%
Return on Capital Employed (ROCE)	-1.85%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	19.73M
Profits Per Employee	151,510
Employee Count	51
Asset Turnover	4.20
Inventory Turnover	6.32

Taxes

Income Tax	-10.73M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	36.13
200-Day Moving Average	n/a
Relative Strength Index (RSI)	20.48
Average Volume (20 Days)	4,791

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Meds Apotek AB had revenue of SEK 1.01 billion and earned 7.73 million in profits. Earnings per share was 0.43.

Revenue	1.01B
Gross Profit	227.94M
Operating Income	-2.41M
Pretax Income	-3.00M
Net Income	7.73M
EBITDA	-284,000
EBIT	-2.41M
Earnings Per Share (EPS)	0.43

Balance Sheet

The company has 45.17 million in cash and 7.05 million in debt, with a net cash position of 38.12 million or 2.05 per share.

Cash & Cash Equivalents	45.17M
Total Debt	7.05M
Net Cash	38.12M
Net Cash Per Share	2.05
Equity (Book Value)	128.40M
Book Value Per Share	6.91
Working Capital	88.88M

Cash Flow

In the last 12 months, operating cash flow was -21.23 million and capital expenditures -598,000, giving a free cash flow of -21.83 million.

Operating Cash Flow	-21.23M
Capital Expenditures	-598,000
Depreciation & Amortization	2.12M
Net Borrowing	-8.78M
Free Cash Flow	-21.83M
FCF Per Share	-1.18

Margins

Gross margin is 22.65%, with operating and profit margins of -0.24% and 0.77%.

Gross Margin	22.65%
Operating Margin	-0.24%
Pretax Margin	-0.30%
Profit Margin	0.77%
EBITDA Margin	-0.03%
EBIT Margin	-0.24%
FCF Margin	n/a

Dividends & Yields

Meds Apotek AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.40%
Shareholder Yield	-3.40%
Earnings Yield	1.59%
FCF Yield	-4.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Meds Apotek AB has an Altman Z-Score of 5.58 and a Piotroski F-Score of 3.

Altman Z-Score	5.58
Piotroski F-Score	3